Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Aug 15, 2024

BUY
$0.63 - $1.14 $1.01 Million - $1.82 Million
1,600,000 New
1,600,000 $1.33 Million
Q4 2023

Feb 12, 2024

BUY
$0.63 - $1.14 $1.01 Million - $1.82 Million
1,600,000 New
1,600,000 $1.33 Million
Q4 2022

Feb 13, 2023

BUY
$2.02 - $3.25 $2.56 Million - $4.12 Million
1,267,000 New
1,267,000 $3.04 Million

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Sofinnova Investments, Inc. Portfolio

Follow Sofinnova Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sofinnova Investments, Inc. with notifications on news.